Researchers from the Innovative Genomics Institute have developed a new CRISPR technique capable of selectively shredding cancer cells, including aggressive strains previously considered undruggable. By precisely targeting malignant cells, this breakthrough offers a highly focused approach to destroying tumors without harming surrounding healthy tissue. The advancement holds significant potential for revolutionizing cancer treatments and tackling some of the most resistant forms of the disease.